What is the Chimeric Therapeutics (ASX: CHM) share price?
The CHM share price is $0.071, up 9.23% for the day, based on the latest available ASX market data.
What is Chimeric Therapeutics's market capitalisation?
Chimeric Therapeutics has a market capitalisation of $2.9M, making it the 1769th-largest security listed on the ASX.
Does Chimeric Therapeutics pay a dividend?
CHM does not currently have a dividend on record. Some companies, particularly those reinvesting in growth or not yet profitable, do not pay dividends.
Is Chimeric Therapeutics profitable?
In its most recent reported period (ending 31 Dec 2025), CHM reported revenue of $0 and a net loss of $11.2M.
How many CHM shares are on issue?
Chimeric Therapeutics has approximately 41,043,099 shares on issue, based on its market capitalisation of $2.9M and current share price.
What sector is Chimeric Therapeutics in?
Chimeric Therapeutics is classified in the Healthcare sector, within the Biotechnology industry on the ASX.
When did Chimeric Therapeutics list on the ASX?
Chimeric Therapeutics listed on the Australian Securities Exchange on 17 Jan 2021.
